Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Maximum_Gain who wrote (3443)	11/23/1999 10:18:00 PM
From: bob beck	Respond to of 4140

They went before the panel and the panel decided that the treatment didn't work well enough, but the FDA, in one of their better judgements, decided that since there was no current treatment for macular degeneration, something was better than nothing so they approved it. If it helps only 5% of the people afflicted with this terrible condition it will be worthwhile. Prediction: 11/24 - Sunrise Technologies doubles in price to over 25. bob